Therapeutic Expertise

To effectively advance oncology clinical development, we must tailor our approaches to the unique characteristics of different cancer types, align patient recruitment with specific treatment pathways, remain adaptable to evolving scientific discoveries, and ensure consistent, efficient trial management on a global scale. At IDDCR, we possess the essential expertise and unwavering commitment to excel in all aspects of oncology clinical research.

Dermatology is a highly subjective therapeutic area, and many primary endpoint assessments require a clinician to evaluate skin lesions. Our dermatology clinical trial management team offers clinical outcome assessments (COAs) and advanced imaging technology, coupled with clinical training and engagement with patients on reliable reporting that all contribute to quality dermatological studies.

Neuroscience research can be complex due to factors like patient recruitment, subjective measurements, placebo effects, and efficacy demonstration. At IDDCR Global Research, we have a proven track record of addressing these challenges and ensuring efficient trial progress.

IDDCR Global Research is a leading force in the fight against infectious diseases. With global experience and deep expertise, we're dedicated to tackling emerging and re-emerging threats. Our focus on infectious disease trials covers viruses, bacteria, fungi, and parasites.

​

Our COVID-19 experience has equipped us with valuable insights for strategic planning, regulatory guidance, and efficient trial execution. We're committed to excellence and stay updated on the latest regulations from key regions like the US and EU.

IDDCR Global Research is a leader in respiratory drug development. We understand the urgent need for innovative therapies to address the global burden of respiratory diseases. Our expertise lies in conducting clinical trials from Phase I to IV, accelerating the path of promising treatments to market.

​

With a global network of experienced investigators, we leverage our deep understanding of respiratory physiology and pathology to deliver efficient and effective clinical research. Whether you're working on a single protocol or a complex development program, IDDCR is your trusted partner in bringing life-changing respiratory therapies to patients.

IDDCR Global Research is a leading force in ophthalmology studies, renowned for our deep understanding of patient experiences and our commitment to precision. Our team possesses a unique perspective, having worked with sponsors, clinical investigators, scientific leaders, and regulatory agencies. This comprehensive understanding allows us to design and execute efficient, protocol-compliant clinical trials.

We specialize in a wide range of ophthalmic conditions, including Retinopathy of Prematurity, Age-related Macular Degeneration (AMD), and Allergic Conjunctivitis.
 

At IDDCR Global Research, we recognize the ongoing challenge posed by cardiovascular disease, the world's leading cause of death. Our strategy prioritizes swift, data-driven solutions to improve cardiovascular outcomes and patient care. With a global footprint, we specialize in a broad range of studies, from early-stage development to post-market surveillance, including research into rare conditions.